Sanjay Nayak serves as Executive at OCULAR THERAPEUTIX, INC, where they oversee executive responsibilities. Since joining the company, Sanjay Nayak has executed 6 insider transactions totaling $89.7K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 23, 2026 involved selling 1,759 shares valued at $14.6K.
Sanjay Nayak currently holds 330,653 shares of OCULAR THERAPEUTIX, INC (OCUL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sanjay Nayak has been a net seller of OCUL stock. They have purchased $0 and sold $89.7K worth of shares.
Sanjay Nayak's most recent insider trade was on Feb 23, 2026, when they sold 1,759 shares at $8.28 per share.
Get notified when new Form 4 filings are submitted
| $12.04 |
| Discretionary |
| Aug 25, 2025 | OCUL | $22.7K | Sale | 1,885 | $12.04 | Discretionary |
| Aug 23, 2024 | OCUL | $16.5K | Sale | 1,832 | $9.02 | Planned |
| May 23, 2024 | OCUL | $13.3K | Sale | 2,274 | $5.84 | Planned |
| Feb 22, 2024 | OCUL | $0 | Award | 80,300 | $N/A | Discretionary |